Alterity Therapeutics
ATHE
11 hedge funds and large institutions have $907K invested in Alterity Therapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
9% more capital invested
Capital invested by funds: $834K → $907K (+$73.1K)
1.45% more ownership
Funds ownership: 0% → 1.46% (+1.5%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
8% less funds holding
Funds holding: 12 → 11 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GT
Greenleaf Trust
Kalamazoo,
Michigan
|
+$66.7K |
| 2 |
Morgan Stanley
New York
|
+$57.3K |
| 3 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$2.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
-$129K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$44.9K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$6.13K |
| 4 |
JP Morgan Chase
New York
|
-$184 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Point72 Asset Management
Stamford,
Connecticut
| $537K | – | – | – |
|
|
2
Morgan Stanley
New York
| $238K | +$57.3K | +14,600 | +33% |
|
|
GT
3
Greenleaf Trust
Kalamazoo,
Michigan
| $69.5K | +$66.7K | +17,000 | New |
|
|
4
BNP Paribas Financial Markets
Paris,
France
| $33.5K | -$6.13K | -1,562 | -16% |
|
|
TLCM
5
Twin Lakes Capital Management
Redwood Shores,
California
| $24.2K | – | – | – |
|
|
EWA
6
EverSource Wealth Advisors
Birmingham,
Alabama
| $2.57K | +$2.46K | +628 | New |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $740 | – | – | – |
|
8
RhumbLine Advisers
Boston,
Massachusetts
| $533 | – | – | – |
|
|
BTI
9
Blue Trust Inc
Alpharetta,
Georgia
| $164 | – | – | – |
|
|
SPIA
10
Steward Partners Investment Advisory
New York
| $25 | – | – | – |
|
|
DB
11
Danske Bank
Copenhagen K,
Denmark
| $4 | – | – | – |
|
|
HWM
12
HB Wealth Management
Atlanta,
Georgia
| – | -$129K | -37,483 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$44.9K | -13,004 | Closed |
|
|
14
JP Morgan Chase
New York
| – | -$184 | -53 | Closed |
|
ATHE Hedge Fund Activity: Q2 2025 in Review
11 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q2 2025, worth a combined $907K — up 8.8% from $834K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ATHE and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Greenleaf Trust, opening a new position worth an estimated $66.7K. The largest seller was HB Wealth Management, exiting entirely with an estimated $129K sold.
- 11 institutional investors held Alterity Therapeutics (ATHE) as of Q2 2025, down from 12 in Q1 2025.
- Funds reported $907K of Alterity Therapeutics stock for Q2 2025, up 8.8% quarter-over-quarter.
- 2 funds opened new Alterity Therapeutics positions in Q2 2025 and 3 closed out, a net change of -1 holder.
- The largest Alterity Therapeutics buyer in Q2 2025 was Greenleaf Trust, an estimated $66.7K added.
- The largest Alterity Therapeutics seller in Q2 2025 was HB Wealth Management, an estimated $129K sold.
Based on aggregated 13F filings for Q2 2025.